Denny George P III's Form 4 filing
Ernexa Therapeutics Inc. (ERNA) · filed Aug 20, 2021
- Accession no.
- 0001062993-21-007818
- Filed
- Aug 20, 2021
- Trade date
- Jul 6-14, 2021
- Filing delay
- 45 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $40.45. Open-market sales total $1.20M. It was filed 45 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Denny George P IIICIK 0001234956 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 | Common Stock | SSaleDisposed | −75,000 | $16.06 | −$1,204,500 | 4,775,117 | Indirect | |
| Jul 8, 2021 | Common Stock | PPurchaseAcquired | +1 | $14.35 | +$14.35 | 1 | Indirect | |
| Jul 9, 2021 | Common Stock | PPurchaseAcquired | +1 | $14.11 | +$14.11 | 2 | Indirect | |
| Jul 14, 2021 | Common Stock | PPurchaseAcquired | +1 | $11.99 | +$11.99 | 3 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.